Literature DB >> 21330389

Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques.

R M Kwee1, M T B Truijman, W H Mess, G J J Teule, J W M ter Berg, C L Franke, A G G C Korten, B J Meems, M H Prins, J M A van Engelshoven, J E Wildberger, R J van Oostenbrugge, M E Kooi.   

Abstract

BACKGROUND AND
PURPOSE: There is a need for improved risk stratification of patients with TIA/stroke and carotid atherosclerosis. The purpose of this study was to prospectively investigate the potential of integrated (18)F-FDG PET/MDCT in identifying vulnerable carotid plaques.
MATERIALS AND METHODS: Fifty patients with TIA/stroke with an ipsilateral carotid plaque causing <70% stenosis and a plaque on the contralateral asymptomatic side underwent integrated (18)F-FDG PET/MDCT within 36.1 ± 20.0 days (range, 9-95 days) of the last symptoms. Carotid plaque (18)F-FDG uptake was measured as both the mean and maximum blood-normalized SUV, known as the TBR. Using MDCT, we assessed volumes of vessel wall and individual plaque components.
RESULTS: Mean TBR was only significantly larger in the ipsilateral plaques of patients who were imaged within 38 days (1.24 ± 0.04 [SE] versus 1.17 ± 0.05, P = .014). This also accounted for maximum TBR (1.53 ± 0.06 versus 1.42 ± 0.06, P = .015). MDCT-assessed vessel wall and LRNC volumes were larger in ipsilateral plaques of all patients (982.3 ± 121.3 versus 811.3 ± 106.6 mm(3), P = .016; 164.7 ± 26.1 versus 134.3 ± 35.2 mm(3), P = .026, respectively).
CONCLUSIONS: In the present study, (18)F-FDG PET only detected significant differences between ipsilateral and contralateral asymptomatic plaques in patients with TIA/stroke who were imaged within 38 days, whereas MDCT detected larger vessel wall and LRNC volumes, regardless of time after symptoms. In view of the substantial overlap in measurements of both sides, it remains to be determined whether the differences we found will be clinically meaningful.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330389      PMCID: PMC7965558          DOI: 10.3174/ajnr.A2381

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  17 in total

1.  Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study.

Authors:  J N E Redgrave; J K Lovett; P J Gallagher; P M Rothwell
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

2.  MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1991-05-25       Impact factor: 79.321

3.  Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

Authors:  Nobuhiro Tahara; Hisashi Kai; Masatoshi Ishibashi; Hiroyuki Nakaura; Hayato Kaida; Kenkichi Baba; Naofumi Hayabuchi; Tsutomu Imaizumi
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

4.  Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging.

Authors:  Tobias Saam; Jianming Cai; Lin Ma; You-Quan Cai; Marina S Ferguson; Nayak L Polissar; Thomas S Hatsukami; Chun Yuan
Journal:  Radiology       Date:  2006-08       Impact factor: 11.105

5.  Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis.

Authors:  P M Rothwell; M Eliasziw; S A Gutnikov; A J Fox; D W Taylor; M R Mayberg; C P Warlow; H J M Barnett
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

6.  Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.

Authors:  David Izquierdo-Garcia; John R Davies; Martin J Graves; James H F Rudd; Jonathan H Gillard; Peter L Weissberg; Tim D Fryer; Elizabeth A Warburton
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

7.  Asymptomatic internal carotid artery stenosis defined by ultrasound and the risk of subsequent stroke in the elderly. The Cardiovascular Health Study.

Authors:  W T Longstreth; L Shemanski; D Lefkowitz; D H O'Leary; J F Polak; S K Wolfson
Journal:  Stroke       Date:  1998-11       Impact factor: 7.914

8.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

9.  Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET.

Authors:  M Angels M Angels Font; Alex Fernandez; Ana Carvajal; Cristina Gamez; Lina Badimon; Mark Slevin; Jerzy Krupinski
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Assessment of atherosclerotic carotid plaque volume with multidetector computed tomography angiography.

Authors:  Thomas T de Weert; Cécile de Monyé; Erik Meijering; Ronald Booij; Wiro J Niessen; Diederik W J Dippel; Aad van der Lugt
Journal:  Int J Cardiovasc Imaging       Date:  2008-03-29       Impact factor: 2.357

View more
  12 in total

1.  High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.

Authors:  Fabien Hyafil; Andreas Schindler; Dominik Sepp; Tilman Obenhuber; Anna Bayer-Karpinska; Tobias Boeckh-Behrens; Sabine Höhn; Marcus Hacker; Stephan G Nekolla; Axel Rominger; Martin Dichgans; Markus Schwaiger; Tobias Saam; Holger Poppert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-03       Impact factor: 9.236

Review 2.  Molecular imaging in atherosclerosis: FDG PET.

Authors:  David Rosenbaum; Antoine Millon; Zahi A Fayad
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

3.  Predictive medicine: towards a multi-parametric imaging for a personal risk stratification.

Authors:  Eric Guedj; Serge Cammilleri; Antoine Verger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-02       Impact factor: 9.236

4.  18F-FDG PET/CT imaging factors that predict ischaemic stroke in cancer patients.

Authors:  Jahae Kim; Kang-Ho Choi; Ho-Chun Song; Joon-Tae Kim; Man-Seok Park; Ki-Hyun Cho
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-29       Impact factor: 9.236

5.  Carotid Plaque Positron Emission Tomography Imaging and Cerebral Ischemic Disease.

Authors:  Salama Chaker; Khalid Al-Dasuqi; Hediyeh Baradaran; Michelle Demetres; Diana Delgado; Sadek Nehmeh; Joseph R Osborne; Paul J Christos; Hooman Kamel; Ajay Gupta
Journal:  Stroke       Date:  2019-07-05       Impact factor: 7.914

6.  Sonographic characteristics of carotid artery plaques: Implications for follow-up planning?

Authors:  A Casadei; M Floreani; R Catalini; C Serra; A P Assanti; P Conci
Journal:  J Ultrasound       Date:  2012-06-23

7.  Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT.

Authors:  Karel-Jan D F Lensen; Alper M van Sijl; Alexandre E Voskuyl; Conny J van der Laken; Martijn W Heymans; Emile F I Comans; Mike T Nurmohamed; Yvo M Smulders; Ronald Boellaard
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

Review 8.  18F-FDG Uptake on PET/CT in Symptomatic versus Asymptomatic Carotid Disease: a Meta-Analysis.

Authors:  Mohammed M Chowdhury; Jason M Tarkin; Nicholas R Evans; Elizabeth Le; Elizabeth A Warburton; Paul D Hayes; James H F Rudd; Patrick A Coughlin
Journal:  Eur J Vasc Endovasc Surg       Date:  2018-05-02       Impact factor: 7.069

9.  18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques.

Authors:  Kjersti Johnsrud; Karolina Skagen; Therese Seierstad; Mona Skjelland; David Russell; Mona-Elisabeth Revheim
Journal:  J Nucl Cardiol       Date:  2017-12-05       Impact factor: 5.952

Review 10.  Neuroimaging of the vulnerable plaque.

Authors:  Karl-Olof Lovblad; Vitor Mendes-Pereira; Valentina Garibotto; Frederic Assal; Jean-Pierre Willi; Roman Stztajzel; Osman Ratib; Maria Isabel Vargas
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.